News
The most recent news and industry headlines are presented in this section. Our dedicated team closely observes the pharmaceutical industry and keeps you informed of the most recent developments around the Europe.
QIAGEN receives European IVDR certification for QIAstat-Dx syndromic testing instruments and assays
Friday, September 27, 2024QIAGEN announced that its QIAstatDx syndromic testing systems and associated assays have received CEmarking under the European Unions new InVitro Diagnostic Medical Devices Regulation IVDR This certification includes the widelyused QIAstatDx Analyzer
Minovia Therapeutics Announces FDA Clearance of IND Application for a Phase Ib Clinical Trial of MNV-201 in Low Risk Myelodysplastic Syndrome
Friday, September 27, 2024Minovia Therapeutics Ltd a clinical stage biopharmaceutical company advancing mitochondrial cell therapies for primary and secondary mitochondrial diseases today announced that the US Food and Drug Administration FDA has cleared its Investigational N...
Boehringer Ingelheim expands cancer research at its Vienna site
Thursday, September 26, 2024Boehringer Ingelheim is one of the worlds leading researchoriented pharmaceutical companies The clinical pipeline is constantly being further developed and Boehringer Ingelheim expects new approvals also in oncology in the coming years
Orion and Aitia enter AI-Driven Drug Discovery and Drug Simulation Collaboration in Oncology
Thursday, September 26, 2024Orion Corporation and Aitia an AIenabled biotechnology company and the leader in the development and application of Causal AI and Digital Twins to discover and develop new drugs announced today that the companies have entered into agreement to create
Junshi Biosciences Announces European Commission Approval for Marketing of Toripalimab
Wednesday, September 25, 2024Shanghai Junshi Biosciences Co Ltd a leading innovationdriven biopharmaceutical company dedicated to the discovery development and commercialization of novel therapies and its whollyowned subsidiary TopAlliance Biosciences Inc TopAlliance Biosciences...
Araris Biotech AG Expands its IP Portfolio with the Acquisition of Innate Pharma’s Portfolio of Transglutaminase Patents for the Generation of Antibody-Drug Conjugates (ADCs)
Wednesday, September 25, 2024Araris Biotech AG a Swiss oncology biotech company developing nextgeneration antibodydrug conjugates ADCs today announced it has entered into an Agreement with Innate Pharma Innate Under the agreement Innate will assign its portfolio of patents
QIAGEN and Bode Technology partner to advance use of GEDmatch PRO forensic genetic genealogy database
Tuesday, September 24, 2024QIAGEN NV announced that Bode Technology the largest private US forensics laboratory company with a growing presence in other regions would become the exclusive global commercial partner for the GEDmatch PRO genealogy database
DBV Technologies Completes Screening for the VITESSE Phase 3 Clinical Trial
Tuesday, September 24, 2024DBV Technologies a clinicalstage biopharmaceutical company today announced that patient screening is complete for the Phase trial VITESSE Viaskin Peanut Immunotherapy Trial to Evaluate Safety Simplicity and Efficacy using the modified
Agarose Bead Technologies expands facility to meet rising global demand for novel therapies market
Tuesday, September 24, 2024Agarose Bead Technologies ABT a leading manufacturer of highquality agarose resins proudly announces the completion of a major expansion at its facility located in Northern Spain Burgos The sqm addition positions ABT as one of Europes largest manufa...
Agilent Completes Acquisition of BIOVECTRA
Monday, September 23, 2024Agilent Technologies Inc announced the company has completed its acquisition of BIOVECTRA a Canadabased contract development and manufacturing organization CDMO that specializes in biologics highly potent active pharmaceutical ingredients
